Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... - DigitalJournal.com (press release) ( Wed, 01 Sep 2010 14:09:03 GMT+00:00 ) Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... DigitalJournal.com (press release) ... directed at a variety of cancer indications, including those of the prostate, kidney, pancreas, ovary, bladder, lung, colon, breast and skin. ... and more »
Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... - Centre Daily Times ( Thu, 02 Sep 2010 10:08:52 GMT+00:00 ) Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... Centre Daily Times ... directed at a variety of cancer indications, including those of the prostate, kidney, pancreas, ovary, bladder, lung, colon, breast and skin. ... and more »
J Myers aka HackReviewerGuy '6 Star Reviews 12' - Blog 16 - MOG (blog) ( Wed, 01 Sep 2010 21:41:03 GMT+00:00 )
Selenium may decrease bladder cancer risk - St. Louis Globe-Democrat ( Thu, 02 Sep 2010 05:23:10 GMT+00:00 )
Selenium intake linked to decreased risk of bladder cancer - Sify ( Wed, 01 Sep 2010 08:36:55 GMT+00:00 )
Doctors Offer Free Prostate Screenings - WIBW ( Fri, 03 Sep 2010 02:58:36 GMT+00:00 )
Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... - Trading Markets (press release) ( Wed, 01 Sep 2010 14:11:08 GMT+00:00 ) Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... Trading Markets (press release) ... directed at a variety of cancer indications, including those of the prostate, kidney, pancreas, ovary, bladder, lung, colon, breast and skin. ... and more »
New antibody-combination therapy boosts human lymphoma cure rate in mouse models - PhysOrg.com ( Thu, 02 Sep 2010 18:40:22 GMT+00:00 )
Afferent Pharmaceuticals Presents Data Supporting Use of P2X3 Antagonists in ... - PharmaLive (press release) (subscription) ( Wed, 01 Sep 2010 13:13:07 GMT+00:00 )
The WHO classification of 1973 is more suitable than the WHO classification of ... - UroToday ( Thu, 02 Sep 2010 07:24:33 GMT+00:00 )
Arnold Palmer Joins Centocor Ortho Biotech and Us TOO International to Launch ... - SunHerald.com (press release) ( Wed, 01 Sep 2010 10:30:18 GMT+00:00 )
Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... - BioMedReports (subscription) ( Wed, 01 Sep 2010 14:37:28 GMT+00:00 ) Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... BioMedReports (subscription) ... directed at a variety of cancer indications, including those of the prostate, kidney, pancreas, ovary, bladder, lung, colon, breast and skin. ... and more »
Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... - PR Newswire (press release) ( Wed, 01 Sep 2010 14:02:28 GMT+00:00 ) Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... PR Newswire (press release) ... directed at a variety of cancer indications, including those of the prostate, kidney, pancreas, ovary, bladder, lung, colon, breast and skin. ... and more »
Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... - Virtual Press Office (press release) ( Wed, 01 Sep 2010 14:27:02 GMT+00:00 ) Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical ... Virtual Press Office (press release) ... directed at a variety of cancer indications, including those of the prostate, kidney, pancreas, ovary, bladder, lung, colon, breast and skin. ... and more »
Afferent Pharmaceuticals Presents Data Supporting Use of P2X3 Antagonists in ... - PharmaLive.com (press release) ( Wed, 01 Sep 2010 13:11:29 GMT+00:00 )
Will conquer cancer: Lisa Ray - indiablooms ( Wed, 01 Sep 2010 14:02:05 GMT+00:00 )
Complete the Form Below
